Replies to post #213783 on Biotech Values

[DewDiligence]

Allergan and Intercept are really setting the stage here for ENTA.

Looking forward to the EDP-305 data in presumed NAFLD patients to be presented at AASLD in October.

[tika1]

Or it may be good news for small caps CNAT or GALT.